Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Evax Technologies raises $1.8mm in first round

Executive Summary

Evax Technologies raised $1.8mm in first-round debt and equity ($1.8mm pre-money, $3.6mm post-money) from Bayer Innovation (Bayer's new captive venture fund), Global Life Sciences (also a new fund), Technologie Holding, and Oxford Bioscience Partners
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies